These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5424901)
21. [Colchicine in dermatotherapy]. Sterry W Hautarzt; 1984 Feb; 35(2):65-7. PubMed ID: 6706580 [No Abstract] [Full Text] [Related]
22. Fluorouracil cream (Efudix) in dermatology. Drug Ther Bull; 1973 Nov; 11(24):94-6. PubMed ID: 4771790 [No Abstract] [Full Text] [Related]
23. Immunosuppressant and cytotoxic drugs: unapproved uses or indications. Abel EA Clin Dermatol; 2000; 18(1):95-101. PubMed ID: 10701090 [No Abstract] [Full Text] [Related]
24. [Immunosuppressive therapy of skin diseases]. Ruszczak Z Przegl Dermatol; 1980; 67(1):1-8. PubMed ID: 7375648 [No Abstract] [Full Text] [Related]
25. [Pimecrolimus (SDZ ASM 981). Current state of research]. Dissemond J; Goos M; Wagner SN Dtsch Med Wochenschr; 2002 May; 127(22):1199-203. PubMed ID: 12035117 [No Abstract] [Full Text] [Related]
26. [Treatment of some skin diseases with immunosuppressive drugs]. Wasik F; Miklaszewska M; Nockowska M Przegl Dermatol; 1975; 62(1):103-8. PubMed ID: 1111024 [No Abstract] [Full Text] [Related]
28. Thalidomide for dermatology: a review of clinical uses and adverse effects. Faver IR; Guerra SG; Su WP; el-Azhary R Int J Dermatol; 2005 Jan; 44(1):61-7. PubMed ID: 15663665 [No Abstract] [Full Text] [Related]
29. Treatment of psoriasis. Part 2. Systemic therapies. Lebwohl M; Ali S J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913 [TBL] [Abstract][Full Text] [Related]
30. [Indications and limits for retinoid treatments in dermatology]. Puissant A; Blanchet-Bardon C Rev Prat; 1983 Jun; 33(35):1853-64. PubMed ID: 6226083 [No Abstract] [Full Text] [Related]
31. [Thalidomide and thrombosis]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2003 Apr; 130(4):489. PubMed ID: 12843869 [No Abstract] [Full Text] [Related]
32. Rheumatoid arthritis in dermatology. Hata T; Kavanaugh A Clin Dermatol; 2006; 24(5):430-7. PubMed ID: 16966022 [TBL] [Abstract][Full Text] [Related]
35. Uses and complications of isotretinoin therapy. Ellis CN; Krach KJ J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947 [TBL] [Abstract][Full Text] [Related]
36. The use and abuse of immunosuppressive agents in dermatology. Bell I; Weinstein GD Arch Dermatol; 1985 Feb; 121(2):195-6. PubMed ID: 3977333 [No Abstract] [Full Text] [Related]
37. Anticipating and preventing infection in patients treated with immunosuppressive medications for dermatologic indications: a dermatologist's checklist. Lehman JS; Wetter DA; Davis MD; el-Azhary RA; Gibson LE; Kalaaji AN J Am Acad Dermatol; 2014 Oct; 71(4):e125-6. PubMed ID: 25219725 [No Abstract] [Full Text] [Related]
38. The rapid onset of multiple squamous cell carcinomas during etanercept treatment for psoriasis. Ly L; Czarnecki D Br J Dermatol; 2007 Nov; 157(5):1076-8. PubMed ID: 17854370 [No Abstract] [Full Text] [Related]
39. [Cytostatic drugs in the treatment of neoplasms, with special consideration of neoplasms and some systemic diseases of the skin]. Kostrzewa J Przegl Dermatol; 1968; 55(2):207-13. PubMed ID: 4878003 [No Abstract] [Full Text] [Related]
40. [Blood histamine in some autoimmune skin diseases following administration of immunosuppressive drugs]. Lańcucki Y; Górkiewicz MN Pol Tyg Lek; 1976 Mar; 31(11):425-7. PubMed ID: 1272923 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]